[The XXXX . Study of prognostic factors in 223 cases].

@entity1 @entity1688 @entity129 @entity8954 @entity16 @entity3002 @entity51 @entity5011 @entity74 @entity2841 @entity912
A retrospective study of 223 @entity1 (111 @entity1 , 112 @entity1 , mean age 40.6 years) with the @entity5011 investigated vital or functional prognostic factors. @entity1 were first seen between 1963 and 1981, when 192 were noted to have @entity129 . Assisted ventilation was required in 152 cases, and 23 @entity1 died, including 5 from cardiocirculatory dysautonomy. Plasma exchange was not used. @entity1 were divided into 3 groups as a function of the degree of maximum @entity912 : group 1 (n = 63) @entity1 had incomplete @entity1688 without assisted ventilation, group 2 (n = 93) incomplete @entity1688 with assisted ventilation, group 3 (n = 62) @entity1688 with or without assisted ventilation. Vital prognosis was related to the severity of @entity16 . Frequency of intercurrent complications, @entity74 and mortality increased with maximal severity of @entity51 . The 3 groups did not differ as a function of previous history, mode of onset of @entity8954 , duration of extension phase of @entity912 , or @entity2841 protein content at the first examination during the extension phase of the paralyses. It is therefore impossible at an early stage of the disease to predict future @entity51 . The cumulative percentage of @entity1 who recovered a normal muscular force in limbs and cranial territories was 48 p. 100 after one year and 60 p. 100 after two years (actuarial values). The functional prognosis depends upon the degree of @entity51 at maximum @entity912 and duration of the plateau phase. Probability of full muscular strength recovery was lower in group 3 and in those @entity1 with a plateau phase duration longer than 2 weeks. Independently of groups, motility recovery rate was markedly higher in @entity1 with a plateau phase duration of less than one week. Motility recuperation was independent of age, sex, duration of extension phase, @entity2841 protein levels during the acute phase, and presence of @entity3002 .
